Oral Microbial Shift Following 1-Month Supplementation of Probiotic Chewable Tablets Containing Lactobacillus reuteri UBLRu-87 as an Adjunct to Phase 1 Periodontal Therapy in Chronic Periodontitis Patients: A Randomized Controlled Clinical Trial

CONTEXT: Although Lactobacilli as a probiotic was established as a treatment for a wide range of systemic infections, its role in periodontitis and oral microbiota is still under investigation. AIMS: The present randomized clinical trial was aimed to evaluate the effects of probiotic chewable tablet...

Descripción completa

Detalles Bibliográficos
Autores principales: Jebin, A. Aysha, Nisha, K. J., Padmanabhan, Shyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237819/
https://www.ncbi.nlm.nih.gov/pubmed/34220150
http://dx.doi.org/10.4103/ccd.ccd_135_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237819/
https://www.ncbi.nlm.nih.gov/pubmed/34220150
http://dx.doi.org/10.4103/ccd.ccd_135_20

Ejemplares similares